• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PNV
Click for more information
1.97% $1.99

POLYNOVO LIMITED - Announcements

Market Cap $1.699B  ! watchlist Created with Sketch. Add to my watchlist

PolyNovo Limited is an Australia-based medical device company, which is focused on... PolyNovo Limited is an Australia-based medical device company, which is focused on advanced wound care that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
PNV Ceasing to be a substantial holder19/09/24
PNV S&P DJI Announces September 2019 Quarterly RebalancePRICE SENSITIVE06/09/19 download Created with Sketch. 148.88KB
PNV Change Director's Interest Notice- Rathie Purchase12/03/19
PNV Director Share Purchase08/03/19
PNV Half Yearly Report and AccountsPRICE SENSITIVE21/02/19
PNV PolyNovo Purchases additional production facilityPRICE SENSITIVE18/01/19
PNV Malaysia Regulatory ApprovalPRICE SENSITIVE18/01/19
PNV Appendix 3B Leon Hoare18/01/19
PNV H1 Sales FY19 PolyNovoPRICE SENSITIVE07/01/19
PNV Appendix 3B Exercise Options JS20/12/18
PNV Jan-Marcel Gielen appointed as CFO and Company Secretary10/12/18
PNV Change of Director's Interest Notice30/11/18
PNV PolyNovo Sales FY19 YTD Market UpdatePRICE SENSITIVE28/11/18
PNV Appendix 3B22/11/18
PNV Results of Annual General Meeting16/11/18
PNV AGM Chairman and CEO Address to ShareholdersPRICE SENSITIVE16/11/18
PNV PolyNovo CFO Resignation07/11/18
PNV NovoSorb BTM aaproved for sale in IndiaPRICE SENSITIVE01/11/18
PNV Notice of Annual General Meeting/Proxy Form16/10/18
PNV Amendment to Annual Report - Marketable Parcel Update12/10/18
PNV Change of Director's Interest Notice25/09/18
PNV Change of Director's Interest Notice25/09/18
PNV S&P DJI Announces September 2018 Quarterly RebalancePRICE SENSITIVE07/09/18
PNV Change of Director's Interest Notice30/08/18
PNV Change of Director's Interest Notice27/08/18
PNV Change of Director's Interest Notice20/08/18
PNV Annual Report to Shareholders and Appendix 4EPRICE SENSITIVE16/08/18
PNV Appendix 4G16/08/18
PNV Corporate Governance Statement - Year Ending 30 June 201816/08/18
PNV NovoSorb BTM registered with TGA14/08/18
PNV Final Patient enrolled in BARDA Feasibility Burn TrialPRICE SENSITIVE02/08/18
PNV NovoSorb BTM approved for sale in Saudi ArabiaPRICE SENSITIVE27/07/18 download Created with Sketch. 154.34KB
PNV PolyNovo offers World Class skin product to Greek Fire26/07/18 download Created with Sketch. 203.08KB
PNV Corporate Governance Statement - Year Ending 30 June 201727/06/18 download Created with Sketch. 76.08KB
PNV Ceasing to be a substantial holder14/06/18 download Created with Sketch. 177.94KB
PNV Final patient enrolled in CE Mark Burn TrialPRICE SENSITIVE22/05/18 download Created with Sketch. 134.93KB
PNV Change in substantial holding15/05/18
PNV Change of Director's Interest Notice15/05/18
PNV Change of Director's Interest Notice10/05/18
PNV Appendix 3B02/05/18
PNV Change of Director's Interest Notice01/05/18
PNV Change of Director's Interest Notice30/04/18
PNV PolyNovo Announces Breast Device Development ProgramPRICE SENSITIVE03/04/18
PNV Change in substantial holding27/03/18
PNV Change of Director's Interest Notice27/03/18
PNV Resignation of Joint Company Secretary20/02/18
PNV Results announcement, App 4D and Half-Year Financial ReportPRICE SENSITIVE15/02/18
PNV First US Surgeon Podium presentations of Novosorb BTM01/02/18
PNV COO, CFO and Company Secretary23/01/18
PNV PolyNovo Announces Breast Device Development AgreementPRICE SENSITIVE18/01/18
PNV Hong Kong Investor Presentation14/12/17
PNV CEO Presentation - Financial News Network CEO Sessions21/11/17
PNV Results of Meeting16/11/17
PNV Chairman's Address to Shareholders16/11/17
PNV Change of Director's Interest Notice03/11/17
PNV Appendix 3B03/11/17
PNV Change in substantial holding02/11/17
PNV Change of Director's Interest Notice31/10/17
PNV Change of Director's Interest Notice31/10/17
PNV Change of Director's Interest Notice30/10/17
PNV Change of Director's Interest Notice30/10/17
PNV Change of Director's Interest Notice30/10/17
PNV Change of Director's Interest Notice30/10/17
PNV Appendix 3B27/10/17
PNV Share Purchase Plan27/10/17
PNV Resignation of Joint Company Secretary19/10/17
PNV Change of Director's Interest Notice17/10/17
PNV Appendix 3B17/10/17
PNV PolyNovo signs MOU for global breast partnershipPRICE SENSITIVE16/10/17
PNV Change of Director's Interest Notice12/10/17
PNV Change of Director's Interest Notice12/10/17
PNV Appendix 3B12/10/17
PNV New Sales and Repeat Orders in the USPRICE SENSITIVE11/10/17
PNV Notice of Annual General Meeting/Proxy Form09/10/17
PNV PolyNovo's Israel Market EntryPRICE SENSITIVE04/10/17
PNV Record Date for Share Purchase Plan (SPP)02/10/17
PNV Share Purchase Plan (SPP) OfferPRICE SENSITIVE02/10/17
PNV Section 708A Notice29/09/17
PNV Appendix 3B29/09/17
PNV Investor Presentation25/09/17
PNV Placement and Share Purchase PlanPRICE SENSITIVE25/09/17
PNV Trading HaltPRICE SENSITIVE21/09/17
PNV Further US Sales for NovoSorb BTMPRICE SENSITIVE14/09/17
PNV First US Sales of BTM NovosorbPRICE SENSITIVE01/09/17
PNV Change of Director's Interest Notice30/08/17
PNV Appendix 3B30/08/17
PNV Change of Director's Interest Notice28/08/17
PNV Annual Report to shareholders and Appendix 4EPRICE SENSITIVE24/08/17
PNV Appendix 4G24/08/17
PNV Change of Director's Interest Notice04/07/17
PNV Change of Director's Interest Notice04/07/17
PNV Appendix 3B04/07/17
PNV Change of Director's Interest Notice23/06/17
PNV Greenwood and NovoSorb02/06/17
PNV Business update and earnings guidancePRICE SENSITIVE19/05/17
PNV Research project collaboration with Beta Cell TechnologiesPRICE SENSITIVE12/05/17
PNV Change of Director's Interest Notice01/05/17
PNV Release of Shares from Escrow13/04/17
PNV ASX CEO Sessions, PolyNovo Presentation11/04/17
PNV Change of Director's Interest Notice06/03/17
PNV Ceasing to be a substantial holder
19/09/24
PNV S&P DJI Announces September 2019 Quarterly Rebalance
06/09/19PRICE SENSITIVE download Created with Sketch. 148.88KB
PNV Change Director's Interest Notice- Rathie Purchase
12/03/19
PNV Director Share Purchase
08/03/19
PNV Half Yearly Report and Accounts
21/02/19PRICE SENSITIVE
PNV PolyNovo Purchases additional production facility
18/01/19PRICE SENSITIVE
PNV Malaysia Regulatory Approval
18/01/19PRICE SENSITIVE
PNV Appendix 3B Leon Hoare
18/01/19
PNV H1 Sales FY19 PolyNovo
07/01/19PRICE SENSITIVE
PNV Appendix 3B Exercise Options JS
20/12/18
PNV Jan-Marcel Gielen appointed as CFO and Company Secretary
10/12/18
PNV Change of Director's Interest Notice
30/11/18
PNV PolyNovo Sales FY19 YTD Market Update
28/11/18PRICE SENSITIVE
PNV Appendix 3B
22/11/18
PNV Results of Annual General Meeting
16/11/18
PNV AGM Chairman and CEO Address to Shareholders
16/11/18PRICE SENSITIVE
PNV PolyNovo CFO Resignation
07/11/18
PNV NovoSorb BTM aaproved for sale in India
01/11/18PRICE SENSITIVE
PNV Notice of Annual General Meeting/Proxy Form
16/10/18
PNV Amendment to Annual Report - Marketable Parcel Update
12/10/18
PNV Change of Director's Interest Notice
25/09/18
PNV Change of Director's Interest Notice
25/09/18
PNV S&P DJI Announces September 2018 Quarterly Rebalance
07/09/18PRICE SENSITIVE
PNV Change of Director's Interest Notice
30/08/18
PNV Change of Director's Interest Notice
27/08/18
PNV Change of Director's Interest Notice
20/08/18
PNV Annual Report to Shareholders and Appendix 4E
16/08/18PRICE SENSITIVE
PNV Appendix 4G
16/08/18
PNV Corporate Governance Statement - Year Ending 30 June 2018
16/08/18
PNV NovoSorb BTM registered with TGA
14/08/18
PNV Final Patient enrolled in BARDA Feasibility Burn Trial
02/08/18PRICE SENSITIVE
PNV NovoSorb BTM approved for sale in Saudi Arabia
27/07/18PRICE SENSITIVE download Created with Sketch. 154.34KB
PNV PolyNovo offers World Class skin product to Greek Fire
26/07/18 download Created with Sketch. 203.08KB
PNV Corporate Governance Statement - Year Ending 30 June 2017
27/06/18 download Created with Sketch. 76.08KB
PNV Ceasing to be a substantial holder
14/06/18 download Created with Sketch. 177.94KB
PNV Final patient enrolled in CE Mark Burn Trial
22/05/18PRICE SENSITIVE download Created with Sketch. 134.93KB
PNV Change in substantial holding
15/05/18
PNV Change of Director's Interest Notice
15/05/18
PNV Change of Director's Interest Notice
10/05/18
PNV Appendix 3B
02/05/18
PNV Change of Director's Interest Notice
01/05/18
PNV Change of Director's Interest Notice
30/04/18
PNV PolyNovo Announces Breast Device Development Program
03/04/18PRICE SENSITIVE
PNV Change in substantial holding
27/03/18
PNV Change of Director's Interest Notice
27/03/18
PNV Resignation of Joint Company Secretary
20/02/18
PNV Results announcement, App 4D and Half-Year Financial Report
15/02/18PRICE SENSITIVE
PNV First US Surgeon Podium presentations of Novosorb BTM
01/02/18
PNV COO, CFO and Company Secretary
23/01/18
PNV PolyNovo Announces Breast Device Development Agreement
18/01/18PRICE SENSITIVE
PNV Hong Kong Investor Presentation
14/12/17
PNV CEO Presentation - Financial News Network CEO Sessions
21/11/17
PNV Results of Meeting
16/11/17
PNV Chairman's Address to Shareholders
16/11/17
PNV Change of Director's Interest Notice
03/11/17
PNV Appendix 3B
03/11/17
PNV Change in substantial holding
02/11/17
PNV Change of Director's Interest Notice
31/10/17
PNV Change of Director's Interest Notice
31/10/17
PNV Change of Director's Interest Notice
30/10/17
PNV Change of Director's Interest Notice
30/10/17
PNV Change of Director's Interest Notice
30/10/17
PNV Change of Director's Interest Notice
30/10/17
PNV Appendix 3B
27/10/17
PNV Share Purchase Plan
27/10/17
PNV Resignation of Joint Company Secretary
19/10/17
PNV Change of Director's Interest Notice
17/10/17
PNV Appendix 3B
17/10/17
PNV PolyNovo signs MOU for global breast partnership
16/10/17PRICE SENSITIVE
PNV Change of Director's Interest Notice
12/10/17
PNV Change of Director's Interest Notice
12/10/17
PNV Appendix 3B
12/10/17
PNV New Sales and Repeat Orders in the US
11/10/17PRICE SENSITIVE
PNV Notice of Annual General Meeting/Proxy Form
09/10/17
PNV PolyNovo's Israel Market Entry
04/10/17PRICE SENSITIVE
PNV Record Date for Share Purchase Plan (SPP)
02/10/17
PNV Share Purchase Plan (SPP) Offer
02/10/17PRICE SENSITIVE
PNV Section 708A Notice
29/09/17
PNV Appendix 3B
29/09/17
PNV Investor Presentation
25/09/17
PNV Placement and Share Purchase Plan
25/09/17PRICE SENSITIVE
PNV Trading Halt
21/09/17PRICE SENSITIVE
PNV Further US Sales for NovoSorb BTM
14/09/17PRICE SENSITIVE
PNV First US Sales of BTM Novosorb
01/09/17PRICE SENSITIVE
PNV Change of Director's Interest Notice
30/08/17
PNV Appendix 3B
30/08/17
PNV Change of Director's Interest Notice
28/08/17
PNV Annual Report to shareholders and Appendix 4E
24/08/17PRICE SENSITIVE
PNV Appendix 4G
24/08/17
PNV Change of Director's Interest Notice
04/07/17
PNV Change of Director's Interest Notice
04/07/17
PNV Appendix 3B
04/07/17
PNV Change of Director's Interest Notice
23/06/17
PNV Greenwood and NovoSorb
02/06/17
PNV Business update and earnings guidance
19/05/17PRICE SENSITIVE
PNV Research project collaboration with Beta Cell Technologies
12/05/17PRICE SENSITIVE
PNV Change of Director's Interest Notice
01/05/17
PNV Release of Shares from Escrow
13/04/17
PNV ASX CEO Sessions, PolyNovo Presentation
11/04/17
PNV Change of Director's Interest Notice
06/03/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$1.99 		Change
-0.040(1.97%) 		Mkt cap ! $1.699B
Open High Low Value Volume
$2.04 $2.05 $1.96 $1.644M 824.2K

Buyers (Bids)

No. Vol. Price($)
1 4210 $1.97
 

Sellers (Offers)

Price($) Vol. No.
$1.99 3578 2
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$1.98 		  Change
-0.040 ( 2.41 %)
Open High Low Volume
$2.04 $2.05 $1.96 197212
Last updated 15.59pm 21/11/2024 ?
PNV (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.